Evelo Biosciences, Inc. (NASDAQ:EVLO)

About the company

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

98

CEO

Balkrishan Gill

Exchange

NASDAQ

Website

http://www.evelobio.com

$NoneM

Total Revenue

98

Employees

$143.36M

Market Capitalization

-1.64

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382409.47 82729.00 6.14 22.29 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 153076.50 23087.00 51.95 26.98 23.97
AbbVie, Inc. ABBV 146930.84 34057.00 -23.52 17.52 24.65
Bristol Myers Squibb Co. BMY 113009.51 31006.00 2.74 96.08 3.08
Repligen Corp. RGEN 6456.09 286.00 6.19 281.31 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4248.64 137.00 3.32 -9.25 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3748.16 1.00 34.65 -5.73 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1639.59 None 5.33 -26.30 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1604.12 30.00 5.71 -22.82 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Akcea Therapeutics, Inc. AKCA 1360.91 341.00 2.79 -48.38 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1301.44 None 6.69 -6.16 None
Arcutis Biotherapeutics, Inc. ARQT 1184.00 None 5.05 -18.93 None
Odonate Therapeutics, Inc. ODT 1150.14 None 9.42 -10.22 None
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Aprea Therapeutics, Inc. APRE 769.86 None 6.81 -22.77 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 712.58 14.00 4.60 -14.46 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 645.58 19.00 59.83 -23.21 -151.34
Amneal Pharmaceuticals, Inc. AMRX 621.98 1679.00 4.28 -2.86 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 554.61 None 5.57 -9.64 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
Biospecifics Technologies Corp. BSTC 466.97 40.00 3.79 19.97 61.80
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Fulcrum Therapeutics, Inc. FULC 419.75 1.00 7.07 -6.08 None
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 379.08 6.00 4.15 -4.13 None
Relmada Therapeutics, Inc. RLMD 373.32 0.00 5.57 -31.19 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 321.75 None 7.61 -4.93 None
Urovant Sciences Ltd. UROV 302.10 None -5.36 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Lannett Co., Inc. LCI 270.18 542.00 0.92 -8.89 -5.77
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
Spero Therapeutics, Inc. SPRO 261.63 12.00 3.44 -3.22 -656.72
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Gritstone Oncology, Inc. GRTS 227.88 4.00 2.04 -2.18 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 219.60 12.00 2.43 -6.78 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Liquidia Technologies, Inc. LQDA 173.14 8.00 13.57 -3.51 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 166.14 None 2.50 -10.77 None
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
PhaseBio Pharmaceuticals, Inc. PHAS 126.73 2.00 2.35 -2.65 None
NeuBase Therapeutics, Inc. NBSE 123.62 None 51.94 -2.77 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Checkpoint Therapeutics, Inc. CKPT 70.80 2.00 6.10 -3.05 -949.53
Baudax Bio, Inc. BXRX 67.32 None -1.83 -0.96 None
Navidea Biopharmaceuticals, Inc. NAVB 67.15 1.00 -49.38 -6.08 -65.13
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 58.32 192.00 1.01 -0.36 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 52.89 20.00 1.59 -2.80 -51.58
Menlo Therapeutics, Inc. MNLO 49.01 2.00 4.12 -0.52 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
Oncternal Therapeutics, Inc. ONCT 33.54 3.00 4.30 -1.33 -225.89
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Aileron Therapeutics, Inc. ALRN 32.20 None 4.42 -1.21 None
Acer Therapeutics, Inc. ACER 31.20 3.00 2.28 -1.20 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.97 None 1.33 -0.47 None
Novus Therapeutics, Inc. NVUS 7.35 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.95 5.00 1.62 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Evelo Biosciences to Present Clinical Data from Phase 1/2 Trial of EDP1503 at the ESMO World Congress on Gastrointestinal Cancer Virtual Meeting

6d ago, source: Associated Press

Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that clinical data from the ...

Evelo Biosciences Announces Pricing of Public Offering of Common Stock

13d ago, source: Business Insider

The offering is expected to close on or about June 29, 2020, subject to customary closing conditions. Evelo intends to use the net proceeds from the offering, in addition to its existing cash ...

Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial

13d ago, source: PharmiWeb

CAMBRIDGE, Mass. and LONDON, June 22, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) a clinical stage biotechnology company developing a new modality of orally delivered, systemically ...

Evelo Biosciences, Inc.: Evelo Biosciences Announces Pricing of Public Offering of Common Stock

13d ago, source: Finanznachrichten

Evelo Biosciences, Inc. (Nasdaq: EVLO) ("Evelo"), a clinical stage biotechnology company developing a new modality of orally delivered, systemically ...

Evelo Biosciences to Present Clinical Data from Phase 1/2 Trial of EDP1503 at the ESMO World Congress on Gastrointestinal Cancer Virtual Meeting

6d ago, source: Benzinga.com

CAMBRIDGE, Mass., July 01, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting ...

Evelo Biosciences Announces Proposed Public Offering of Common Stock

13d ago, source: Finanzen

CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) ("Evelo”), a clinical stage biotechnology company developing a new modality of orally delivered ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.